NO20003108L - Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger - Google Patents

Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger

Info

Publication number
NO20003108L
NO20003108L NO20003108A NO20003108A NO20003108L NO 20003108 L NO20003108 L NO 20003108L NO 20003108 A NO20003108 A NO 20003108A NO 20003108 A NO20003108 A NO 20003108A NO 20003108 L NO20003108 L NO 20003108L
Authority
NO
Norway
Prior art keywords
melatonin
pharmaceutical compositions
preparation
energetic
ligands
Prior art date
Application number
NO20003108A
Other languages
English (en)
Other versions
NO20003108D0 (no
Inventor
Sonia Pellissier
Anne Merle
Philippe Delagrange
Caroline Bennejean
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20003108D0 publication Critical patent/NO20003108D0/no
Publication of NO20003108L publication Critical patent/NO20003108L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Anvendelse av melatonin og melatoninergiske Ugander for å oppnå farmasøytiske sammensetninger for forebyggingen ¿ og/eller behandlingen av patologier i det gastrointestinale system.
NO20003108A 1999-06-23 2000-06-16 Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger NO20003108L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908019A FR2795323B1 (fr) 1999-06-23 1999-06-23 Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal

Publications (2)

Publication Number Publication Date
NO20003108D0 NO20003108D0 (no) 2000-06-16
NO20003108L true NO20003108L (no) 2000-12-27

Family

ID=9547206

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003108A NO20003108L (no) 1999-06-23 2000-06-16 Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger

Country Status (15)

Country Link
EP (1) EP1064941A1 (no)
JP (1) JP2001026539A (no)
KR (1) KR20010039680A (no)
CN (1) CN1283455A (no)
AU (1) AU4264800A (no)
BR (1) BR0002772A (no)
CA (1) CA2312432A1 (no)
EA (1) EA002823B1 (no)
FR (1) FR2795323B1 (no)
HU (1) HUP0002377A3 (no)
MX (1) MXPA00006145A (no)
NO (1) NO20003108L (no)
NZ (1) NZ505361A (no)
PL (1) PL340954A1 (no)
ZA (1) ZA200003165B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050249785A1 (en) * 2003-08-13 2005-11-10 Gordon John G Use of melatonin-containing oral supplement with animals
DK1670444T3 (da) * 2003-10-03 2011-08-22 Veijlen N V Anvendelse af IFG-1-serumniveau forhøjende indoleddikesyrederivater til fremstilling af en lægemiddelsammensætning til behandling af forskellige sygdomme
RU2361583C2 (ru) * 2003-10-03 2009-07-20 Вейлен Н.В. Применение соединений, способных повышать уровень igf-1 в сыворотке крови, при приготовлении терапевтической композиции для лечения стадий различных заболеваний, ассоциированных со снижением уровня igf-1 в сыворотке людей и животных
ATE430566T1 (de) 2003-10-03 2009-05-15 Veijlen N V Tierfutterzusammensetzung
CA2644181A1 (en) * 2006-03-20 2007-09-27 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for irritable bowel syndrome
ES2384798B1 (es) * 2011-10-19 2013-06-04 Universidad De Granada Uso de melatonina para el tratamiento y/o prevención de la mucositis.
RU2693044C1 (ru) * 2018-05-28 2019-07-01 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет) ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеч Способ профилактики нпвп-гастропатии
WO2022157563A1 (en) * 2021-01-23 2022-07-28 Cellix Bio Private Limited A pharmaceutical composition comprising lidocaine and melatonin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2729147A1 (fr) * 1995-01-11 1996-07-12 Adir Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2795323A1 (fr) 2000-12-29
JP2001026539A (ja) 2001-01-30
FR2795323B1 (fr) 2001-11-16
PL340954A1 (en) 2001-01-02
MXPA00006145A (es) 2002-10-17
NZ505361A (en) 2002-02-01
HUP0002377A2 (hu) 2002-05-29
EP1064941A1 (fr) 2001-01-03
EA002823B1 (ru) 2002-10-31
KR20010039680A (ko) 2001-05-15
EA200000568A3 (ru) 2001-02-26
EA200000568A2 (ru) 2000-12-25
NO20003108D0 (no) 2000-06-16
ZA200003165B (en) 2001-01-25
HUP0002377A3 (en) 2002-08-28
CN1283455A (zh) 2001-02-14
CA2312432A1 (fr) 2000-12-23
BR0002772A (pt) 2001-01-30
AU4264800A (en) 2001-01-04

Similar Documents

Publication Publication Date Title
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
DE69940769D1 (de) Orale flüssige zusammensetzungen
NO20013770D0 (no) Metoder og blandinger for å öke antall hvite blodceller
HRP920632B1 (en) Oral composition for the treatment of inflammatory bowel deseases
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
EP0709090A3 (en) Compositions for the treatment of resistant tumors
CA2303498A1 (en) Dioxocyclopentyl hydroxamic acids
PT705100E (pt) Guanidinas substituidas terapeuticas
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
NO20003108L (no) Anvendelse av melatoninenergiske ligander ved fremstilling av farmasöytiske sammensetninger
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
ATE325803T1 (de) Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung
NO993784L (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
ATE400277T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
IL118218A (en) Pharmaceutical compositions containing sarcodictyins
GB0016052D0 (en) Ruthenium (II) compounds
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
Stephens Reinventing thalidomide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application